Antidote
21 drugs across 7 manufacturers|21 Generic,0 Brand
The Antidote class contains 21 NDCs from 7 manufacturers (21 generic, 0 brand), at an average NADAC of $2.01 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
21
21G / 0B
Manufacturers
7
Avg $2.0107/unit
Avg 7d Change
+0.21%
Across 15 drugs with changes
7d Activity
of 21 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
7 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Fresenius Kabi USA, LLC manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
ACETYLCYSTEINE market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Antidote class?
The Antidote class contains 21 NDCs from 7 manufacturers — 21 generic and 0 brand products.
What is the average price of Antidote drugs?
The average NADAC for the Antidote class is $2.0107 per unit across 21 NDCs.
Which manufacturers make Antidote drugs?
7 manufacturers make drugs in the Antidote class. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (9), American Regent, Inc. (3), Somerset Therapeutics, LLC (3), Cameron Pharmaceuticals (2), Hospira Inc. (2).
How has Antidote pricing changed recently?
Over the past 7 days, 7 NDCs in this class rose and 8 fell, with a class-wide average change of +0.2%.